Cargando…
Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain Inhibitor
[Image: see text] The nonclassical extracellular signal-related kinase 5 (ERK5) mitogen-activated protein kinase pathway has been implicated in increased cellular proliferation, migration, survival, and angiogenesis; hence, ERK5 inhibition may be an attractive approach for cancer treatment. However,...
Autores principales: | Miller, Duncan C., Reuillon, Tristan, Molyneux, Lauren, Blackburn, Timothy, Cook, Simon J., Edwards, Noel, Endicott, Jane A., Golding, Bernard T., Griffin, Roger J., Hardcastle, Ian, Harnor, Suzannah J., Heptinstall, Amy, Lochhead, Pamela, Martin, Mathew P., Martin, Nick C., Myers, Stephanie, Newell, David R., Noble, Richard A., Phillips, Nicole, Rigoreau, Laurent, Thomas, Huw, Tucker, Julie A., Wang, Lan-Zhen, Waring, Michael J., Wong, Ai-Ching, Wedge, Stephen R., Noble, Martin E. M., Cano, Celine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109144/ https://www.ncbi.nlm.nih.gov/pubmed/35468293 http://dx.doi.org/10.1021/acs.jmedchem.1c01756 |
Ejemplares similares
-
Modulation
of ERK5 Activity as a Therapeutic Anti-Cancer
Strategy
por: Miller, Duncan C., et al.
Publicado: (2023) -
Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach
por: Miller, Duncan C., et al.
Publicado: (2018) -
Cyclin-Dependent
Kinase (CDK) Inhibitors: Structure–Activity
Relationships and Insights into the CDK-2 Selectivity of 6-Substituted
2-Arylaminopurines
por: Coxon, Christopher R., et al.
Publicado: (2016) -
Identification and Characterization of an Irreversible Inhibitor of CDK2
por: Anscombe, Elizabeth, et al.
Publicado: (2015) -
N-Nitro-1H-pyrrole-2-carboxamide
por: Liu, Long, et al.
Publicado: (2011)